Axcella
840 Memorial Drive
Entrance on Blackstone Street, Third Floor
Cambridge
Massachusetts
02139
United States
Tel: 857-320-2200
Fax: 617-441-6243
Website: http://www.axcellahealth.com/
Email: info@axcellahealth.com
About Axcella
Axcella Health is pioneering revolutionary new medicines with a focus on amino acid homeostasis. The company has discovered more than 2,000 diseases with amino acid imbalances and developed a systems pharmacology approach to restore health at the cellular level. Axcella’s proprietary platform is clinically validated across several indication areas, with clinical-stage candidates in muscle, neurodegenerative and liver conditions. Axcella is led by a team with a strong track record of leaving a lasting impact on the therapeutic landscape through the development of novel products. The company was founded by VentureLabs, the Innovation Foundry at Flagship Ventures, and has received additional funding from Fidelity Research & Management Group, Gurnet Point Capital and Nestlé Health Science. Axcella is based in Cambridge, Mass.YEAR FOUNDED:
2010
LEADERSHIP:
CEO: Robert Connelly
CMO: Christopher I. Wright
CFO: Thomas Leggett
JOBS:
Please click here for Axcella job opportunities.
87 articles with Axcella
-
Axcella Appoints Stephen Mitchener, PharmD, to Senior Vice President, Chief Business Officer
10/22/2018
Dr. Mitchener brings 15 years of pharmaceutical industry experience driving domestic and international commercialization, BD&L, operations, and value creation to Axcella.
-
There have been a number of leadership changes in the life sciences industries over the past week. BioSpace compiled a roundup of the changing landscape of the c-suite and boards of directors across the industry.
-
Axcella Appoints Bill Hinshaw as President and Chief Executive Officer
5/31/2018
Mr. Hinshaw is a highly accomplished health care executive with nearly three decades of global pharmaceutical experience and was most recently Executive Vice President and Head of U.S. Oncology at Novartis.
-
Axcella Appoints Manu Chakravarthy, M.D., Ph.D., As Chief Medical Officer
9/14/2017
-
Axcella Appoints Tony Tramontin, Ph.D., As Senior Vice President, Chief Scientific Officer
6/14/2017
-
Axcella Announces The Appointment Of Ivana Magovcevic-Liebisch, Ph.D., J.D., As Executive Vice President, Chief Strategy And Corporate Development Officer
5/11/2017
-
Axcella Augments Leadership Team With The Appointment Of Three Key Hires
1/3/2017